Cargando…
Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability
The nonnucleoside reverse transcriptase inhibitors, used for the treatment of HIV infections, are reported to have low bioavailability pertaining to high first-pass metabolism, high protein binding, and enzymatic metabolism. They also show low permeability across blood brain barrier. The CNS is repo...
Autores principales: | Gupta, Shweta, Kesarla, Rajesh, Chotai, Narendra, Misra, Ambikanandan, Omri, Abdelwahab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294220/ https://www.ncbi.nlm.nih.gov/pubmed/28243600 http://dx.doi.org/10.1155/2017/5984014 |
Ejemplares similares
-
Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma
por: Gupta, Shweta, et al.
Publicado: (2017) -
Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems
por: Gupta, Shweta, et al.
Publicado: (2013) -
Enhanced Oral Bioavailability of Efavirenz by Solid Lipid Nanoparticles: In Vitro Drug Release and Pharmacokinetics Studies
por: Gaur, Praveen Kumar, et al.
Publicado: (2014) -
Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles
por: Wang, Wenrui, et al.
Publicado: (2012) -
Formulation Development and Dissolution Rate Enhancement of Efavirenz by Solid Dispersion Systems
por: Koh, P. T., et al.
Publicado: (2013)